First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study

Autor: E. Van Cutsem, I. Danielewicz, M. P. Saunders, P. Pfeiffer, G. Argilés, C. Borg, R. Glynne-Jones, C. J. A. Punt, A. J. Van de Wouw, M. Fedyanin, D. Stroyakovskiy, H. Kroening, P. Garcia-Alfonso, H. Wasan, A. Falcone, R. Fougeray, A. Egorov, N. Amellal, V. Moiseyenko

Publikováno v: British journal of cancer, 126(11), 1548-1554. Nature Publishing Group
Scientia

Background Therapeutic options are limited in patients with unresectable metastatic colorectal cancer (mCRC) ineligible for intensive chemotherapy. The use of trifluridine/tipiracil plus bevacizumab (TT-B) in this setting was evaluated in the TASCO1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03af4faff5144bcdcf5517b7b9e24306
https://doi.org/10.1038/s41416-022-01737-2

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Should the RAPIDO schedule represent standard of care in locally advanced rectal cancer?

Autor: R, Glynne-Jones, M, Harrison

Publikováno v: Annals of Oncology. 33:745-746

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::327ae558394c8f1ba6382eb88485c3c7
https://doi.org/10.1016/j.annonc.2022.05.002

Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009

Autor: Van Cutsem, E. ^*, Dicato, M., Arber, N., Berlin, J., Cervantes, A., Ciardiello, F., De Gramont, A., Diaz-Rubio, E., Ducreux, M., Geva, R., Glimelius, B., Jones, R. Glynne, Grothey, A., Gruenberger, T., Haller, D., Haustermans, K., Labianca, R., Lenz, H.J., Minsky, B., Nordlinger, B., Ohtsu, A., Pavlidis, N., Rougier, P., Schmiegel, W., Van de Velde, C., Schmoll, H.J., Sobrero, A., Tabernero, J.

Publikováno v: In Annals of Oncology June 2010 21 Supplement 6:vi1-vi10

Managing cancer patients during the COVID-19 pandemic:an ESMO multidisciplinary expert consensus

Autor: G. Curigliano, S. Banerjee, A. Cervantes, M.C. Garassino, P. Garrido, N. Girard, J. Haanen, K. Jordan, F. Lordick, J.P. Machiels, O. Michielin, S. Peters, J. Tabernero, J.Y. Douillard, G. Pentheroudakis, A. Addeo, L. Albiges, P.A. Ascierto, F. Barlesi, C. Caldas, F. Cardoso, I.F. Chaberny, N.I. Cherny, T.K. Choueiri, M.L.K. Chua, C. Criscitiello, E. de Azambuja, D. De Ruysscher, E. de Vries, R. Dent, D. D’Ugo, R. Dziadziuszko, C. Faivre-Finn, E. Felip, M. Garassino, R. Glynne-Jones, V. Golfinopoulos, E. Hamilton, P.A. Jänne, R. Kanesvaran, S.B. Kim, U.G. Liebert, T.S.K. Mok, G. Morgan, R. Obermannova, K. Park, A. Passaro, M. Reck, R. Salazar Soler, F. Scotté, S. Senan, C. Sessa, E. Smyth, R. Soo, J.C. Soria, J. Spicer, F. Strasser, D.S.W. Tan, D. Trapani, E. Van Cutsem, H. van Halteren, P.E. van Schil, G. Veronesi, J. Yang

Publikováno v: Curigliano, G, Banerjee, S, Cervantes, A, Garassino, M C, Garrido, P, Girard, N, Haanen, J, Jordan, K, Lordick, F, Machiels, J P, Michielin, O, Peters, S, Tabernero, J, Douillard, J Y, Pentheroudakis, G, Addeo, A, Albiges, L, Ascierto, P A, Barlesi, F, Caldas, C, Cardoso, F, Chaberny, I F, Cherny, N I, Choueiri, T K, Chua, M L K, Criscitiello, C, de Azambuja, E, De Ruysscher, D, de Vries, E, Dent, R, D'Ugo, D, Dziadziuszko, R, Faivre-Finn, C, Felip, E, Garassino, M, Glynne-Jones, R, Golfinopoulos, V, Hamilton, E, Jänne, P A, Kanesvaran, R, Kim, S B, Liebert, U G, Mok, T S K, Morgan, G, Obermannova, R, Park, K, Passaro, A, Reck, M, Salazar Soler, R, Scotté, F, Senan, S, Sessa, C, Smyth, E, Soo, R, Soria, J C, Spicer, J, Strasser, F, Tan, D S W, Trapani, D, Van Cutsem, E, van Halteren, H, van Schil, P E, Veronesi, G & Yang, J 2020, ' Managing cancer patients during the COVID-19 pandemic : an ESMO multidisciplinary expert consensus ', Annals of Oncology, vol. 31, no. 10, pp. 1320-1335 . https://doi.org/10.1016/j.annonc.2020.07.010
Annals of oncology, Vol. 31, no. 10, p. 1320-1335 (2020)
Annals of Oncology
Annals of Oncology, 31(10), 1320-1335. Oxford University Press

We established an international consortium to review and discuss relevant clinical evidence in order to develop expert consensus statements related to cancer management during the severe acute respiratory syndrome coronavirus 2-related disease (COVID

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38f6fb416f36f1f63a089ba320a7b98c
https://research.vumc.nl/en/publications/0c86f1b4-297a-4ee5-a25a-205957a80d8b